中藥制造行業知名品牌,隸屬于中恒集團,集種植、生產、銷售、研發于一體的現代化綜合型制藥企業,涵蓋中華/晨鐘/中恒等品牌
廣西梧州(zhou)制(zhi)藥(yao)(集(ji)團)股份有(you)限公司(si)(簡稱梧州(zhou)制(zhi)藥(yao)),是(shi)上市公司(si)中恒集(ji)團(股票代碼(ma):600252)的下屬(shu)企(qi)業(ye),系(xi)出(chu)嶺(ling)南中藥(yao)之鄉。嶺(ling)南中藥(yao),歷(li)史悠久,名揚中華,民族瑰(gui)寶。梧州(zhou)制(zhi)藥(yao)在近90年的發(fa)展歷(li)史中,已成為集(ji)種(zhong)植、生產、銷售、研(yan)發(fa)于(yu)一(yi)體(ti)的現代化綜(zong)合型制(zhi)藥(yao)企(qi)業(ye),是(shi)國家高(gao)新技術企(qi)業(ye)。
梧州制(zhi)藥(yao)(yao)(yao)資源豐富(fu),擁有(you)化學原料藥(yao)(yao)(yao)、中(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)(yao)注射(she)劑(ji)(ji)等14個(ge)(ge)(ge)大類劑(ji)(ji)型217個(ge)(ge)(ge)品(pin)(pin)種(其中(zhong)(zhong)(zhong)(zhong)中(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)(yao)制(zhi)劑(ji)(ji)135個(ge)(ge)(ge),化學藥(yao)(yao)(yao)82個(ge)(ge)(ge)),擁有(you)藥(yao)(yao)(yao)品(pin)(pin)注冊證309個(ge)(ge)(ge),獲國(guo)家專利55個(ge)(ge)(ge),全(quan)國(guo)獨(du)有(you)生產(chan)品(pin)(pin)種24個(ge)(ge)(ge),《中(zhong)(zhong)(zhong)(zhong)國(guo)藥(yao)(yao)(yao)典(dian)》收載(zai)品(pin)(pin)種105個(ge)(ge)(ge),國(guo)家中(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)(yao)保(bao)護(hu)品(pin)(pin)種5個(ge)(ge)(ge),國(guo)家醫保(bao)目(mu)(mu)錄品(pin)(pin)種86個(ge)(ge)(ge)(其中(zhong)(zhong)(zhong)(zhong)中(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)(yao)品(pin)(pin)種54個(ge)(ge)(ge),西藥(yao)(yao)(yao)品(pin)(pin)種32個(ge)(ge)(ge))國(guo)家基本藥(yao)(yao)(yao)物(wu)目(mu)(mu)錄品(pin)(pin)種45個(ge)(ge)(ge)(其中(zhong)(zhong)(zhong)(zhong)中(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)(yao)品(pin)(pin)種31個(ge)(ge)(ge),化學藥(yao)(yao)(yao)品(pin)(pin)及生物(wu)制(zhi)品(pin)(pin)14個(ge)(ge)(ge)),以及“中(zhong)(zhong)(zhong)(zhong)華”、“晨鐘”和(he)“中(zhong)(zhong)(zhong)(zhong)恒”等品(pin)(pin)牌,擁有(you)注射(she)用(yong)血栓通、婦炎凈膠囊、中(zhong)(zhong)(zhong)(zhong)華跌打丸(wan)、結石通片等主(zhu)導產(chan)品(pin)(pin)。在發展過程(cheng)中(zhong)(zhong)(zhong)(zhong),梧州制(zhi)藥(yao)(yao)(yao)視產(chan)品(pin)(pin)質(zhi)量(liang)為企業的(de)生命和(he)患者(zhe)的(de)生命,嚴格按照GMP要求,不(bu)斷完善質(zhi)量(liang)管理體系和(he)檢測手段,加(jia)強(qiang)質(zhi)量(liang)全(quan)程(cheng)監(jian)管,保(bao)障藥(yao)(yao)(yao)品(pin)(pin)質(zhi)量(liang)安全(quan)。
梧州制藥(yao)大力實施“產(chan)(chan)業(ye)(ye)興國,科技強(qiang)企(qi)”的創(chuang)新戰略,以(yi)(yi)資金為(wei)(wei)保障(zhang),以(yi)(yi)人(ren)才為(wei)(wei)依托(tuo),以(yi)(yi)科技為(wei)(wei)動(dong)力,以(yi)(yi)市場為(wei)(wei)導向,以(yi)(yi)效益(yi)為(wei)(wei)中心,以(yi)(yi)發(fa)(fa)展(zhan)為(wei)(wei)目標(biao),充(chong)分(fen)發(fa)(fa)揮自身技術人(ren)才和(he)技術平臺優(you)勢,推動(dong)自主創(chuang)新驅(qu)動(dong),加強(qiang)對中藥(yao)前(qian)沿技術、新工(gong)藝、新產(chan)(chan)品的研發(fa)(fa),以(yi)(yi)及(ji)老(lao)產(chan)(chan)品的二(er)次開發(fa)(fa),促進產(chan)(chan)品結構和(he)產(chan)(chan)業(ye)(ye)升(sheng)級,增強(qiang)產(chan)(chan)品的市場競(jing)爭力、產(chan)(chan)業(ye)(ye)的發(fa)(fa)展(zhan)競(jing)爭力和(he)企(qi)業(ye)(ye)的核心競(jing)爭力。
梧州(zhou)制藥(yao)(yao)是我國(guo)(guo)中(zhong)(zhong)藥(yao)(yao)制造前端的(de)一顆璀璨明(ming)珠,專注于研制造福眾生的(de)純正好(hao)藥(yao)(yao)。“十(shi)三(san)五”期間,將圍繞醫(yi)(yi)藥(yao)(yao)健(jian)(jian)(jian)康(kang)(kang)領域的(de)傳承與創新(xin),以(yi)(yi)(yi)中(zhong)(zhong)藥(yao)(yao)產業(ye)鏈為(wei)主體,以(yi)(yi)(yi)消費者健(jian)(jian)(jian)康(kang)(kang)為(wei)延伸(shen),以(yi)(yi)(yi)特色(se)化(hua)學藥(yao)(yao)為(wei)補充,抓住國(guo)(guo)家“十(shi)三(san)五”建(jian)成小康(kang)(kang)社會(hui)和落實“健(jian)(jian)(jian)康(kang)(kang)中(zhong)(zhong)國(guo)(guo)”的(de)戰略規劃的(de)時(shi)機,以(yi)(yi)(yi)國(guo)(guo)家大(da)(da)力促(cu)進(jin)中(zhong)(zhong)醫(yi)(yi)藥(yao)(yao)事業(ye)發(fa)展、大(da)(da)力推(tui)動醫(yi)(yi)藥(yao)(yao)科技(ji)創新(xin)、大(da)(da)力發(fa)展健(jian)(jian)(jian)康(kang)(kang)服(fu)務業(ye)為(wei)契(qi)機,利用廣西(xi)地方政府大(da)(da)力推(tui)進(jin)中(zhong)(zhong)醫(yi)(yi)藥(yao)(yao)壯瑤醫(yi)(yi)藥(yao)(yao)現(xian)代化(hua)的(de)機遇,結合公司的(de)市場與資源優勢,努力成為(wei)廣西(xi)醫(yi)(yi)藥(yao)(yao)健(jian)(jian)(jian)康(kang)(kang)資源的(de)整(zheng)合者,定(ding)位(wei)于打造兩廣區域、國(guo)(guo)內有影響力的(de)醫(yi)(yi)藥(yao)(yao)產業(ye)綜合企業(ye)。